All lobbying filings

EVONIK CORPORATION

Lobbying for EVONIK CORPORATION · Manufacturer of specialty chemicals

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Oct 20, 2025

Official filing document

Bills named in this filing 6

S 623
No IRIS Act of 2025
HR 1415
No IRIS Act of 2025
HR 4
Rescissions Act of 2025
HR 1
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
S 615
Chemical Tax Repeal Act
HR 640
Chemical Tax Repeal Act

Lobbying activity 7

Chemicals/Chemical Industry

Issues related to TSCA reform Issues related to EPA Premanufacturing Notices Issues related to new chemical reviews PFAS/PFOA oversight and regulatory efforts

Environment/Superfund

Oversight of EPA rules and regulations S.623 / H.R.1415 - No IRIS Act Make American Healthy Again (MAHA) GRAS issue

Budget/Appropriations

FY26 appropriations actions H.R. 4 - Rescissions Act of 2025 - (PL 119-28) H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package (PL 119-21)

Taxation/Internal Revenue Code

General issues related to corporate tax S.615/H.R.640 - Chemical Tax Repeal Act H.R. 1 - One Bill Beautiful Bill Act (OBBBA) reconciliation package, Section 899 (PL 119-21)

Trade (domestic/foreign)

U.S./China ongoing trade issues Issues related to various trade agreement discussions USMCA Review Process

Railroads

Issues related to the Surface Transportation Board (STB) and rail mergers

Tariff (miscellaneous tariff bills)

Issues related to the Administrations tariff actions and related Congressional oversight

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.